Clinical trial · Interventional
Resilient Living Program for Patients With Advanced Cancer and Their Caregivers
NCT04480008CI-TRIAL-00072983completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Researchers are trying to find out if the Resilient Living Program will improve quality of life, stress, anxiety, sleep, fatigue, and resilience in patients with advanced cancer and their caregivers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Resilient Living Program | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Resilient Living Program
- description
- All participants will be in the Resilient Living Program arm. Study participation involves participating in a 12-week stress management and resilience training program. This will involve four virtual sessions (video or phone) and answering questions about their health, well-being, and quality of life. There will also be online modules to watch and an accompanying journal (with prompts) to keep.
- interventionNames
- Behavioral: Resilient Living Program
Primary outcomes (2)
- measure
- Change in Perceived Stress
- timeFrame
- Baseline; Week 5 (after 2nd session); Week 9 (after 4th session); Week 12 (one month after completing all sessions)
- description
- Stress, as measured by the Perceived Stress Scale (PSS). The PSS has 14 items, 7 positively stated and 7 negatively stated. Likert-type 5-point scale. Positively stated items reverse coded; scores are summed; scores range 0-56. High score indicates greater stress level.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria for patients: * Age ≥18 years * English fluency * No diagnosed severe cognitive impairment * Diagnosis of stage IV solid tumor cancer * Expected prognosis \>6 \<18 months * Provide written informed consent * Ability to complete questionnaire(s) by themselves or with assistance * Patient baseline distress score ≥4/10 OR identified as having distress that would benefit from program by care team or provider * Ability to do first Resilient Living session in person Inclusion Criteria for caregivers: * Self-identifies as a caregiver of a patient that meets the above cancer diagnosis criteria, and who also participates in the study * Provide written informed consent * Ability to complete questionnaire(s) by themselves or with assistance * Age ≥18 years * English fluency * No diagnosed severe cognitive impairment * Ability to do first Resilient Living session in person Exclusion Criteria: * As determined through self-report, those diagnosed with a history of a psychotic episode will be excluded. * Other psychological co-morbidities such as untreated schizophrenia, bipolar disease
References
Publications (0)
Data not yet available
No reference posted for this study.